Literature DB >> 30033157

Serum haptoglobin and hemopexin levels are depleted in pediatric sickle cell disease patients.

Rayra Pereira Santiago1, Caroline Conceição Guarda1, Camylla Vilas Boas Figueiredo1, Luciana Magalhaes Fiuza1, Milena Magalhães Aleluia1, Corynne Stephanie Ahouefa Adanho1, Magda Oliveira Seixas Carvalho2, Thassila Nogueira Pitanga3, Dalila Luciola Zanette3, Isa Menezes Lyra4, Valma Maria Lopes Nascimento5, Gregory M Vercellotti6, John D Belcher7, Marilda Souza Goncalves1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30033157      PMCID： PMC6389271          DOI： 10.1016/j.bcmd.2018.07.002

Source DB:  PubMed          Journal:  Blood Cells Mol Dis        ISSN： 1079-9796            Impact factor:   3.039


× No keyword cloud information.
  13 in total

1.  Studies on serum haptoglobin: a functional inquiry.

Authors:  C F WHITTEN
Journal:  N Engl J Med       Date:  1962-03-15       Impact factor: 91.245

2.  Lactate dehydrogenase as a biomarker of hemolysis-associated nitric oxide resistance, priapism, leg ulceration, pulmonary hypertension, and death in patients with sickle cell disease.

Authors:  Gregory J Kato; Vicki McGowan; Roberto F Machado; Jane A Little; James Taylor; Claudia R Morris; James S Nichols; Xunde Wang; Mirjana Poljakovic; Sidney M Morris; Mark T Gladwin
Journal:  Blood       Date:  2005-11-15       Impact factor: 22.113

3.  Hypolipidemia in anemia.

Authors:  B Rifkind; M Gale
Journal:  Am Heart J       Date:  1968-12       Impact factor: 4.749

4.  Plasma hemoglobin and hemoglobin fractions in sickle cell crisis.

Authors:  H N Naumann; L W Diggs; L Barreras; B J Williams
Journal:  Am J Clin Pathol       Date:  1971-08       Impact factor: 2.493

5.  Soluble CD163 levels in children with sickle cell disease.

Authors:  Holger Jon Moller; Marianne Jensby Nielsen; Jack Bartram; Moira C Dick; Susan E Height; Soren K Moestrup; David C Rees
Journal:  Br J Haematol       Date:  2011-02-20       Impact factor: 6.998

6.  Acute phase reactants and severity of homozygous sickle cell disease.

Authors:  C C Hedo; Y A Aken'ova; I E Okpala; A O Durojaiye; L S Salimonu
Journal:  J Intern Med       Date:  1993-06       Impact factor: 8.989

7.  Vasculopathy in sickle cell disease: Biology, pathophysiology, genetics, translational medicine, and new research directions.

Authors:  Gregory J Kato; Robert P Hebbel; Martin H Steinberg; Mark T Gladwin
Journal:  Am J Hematol       Date:  2009-09       Impact factor: 10.047

8.  The effect of testosterone in pharmacological doses on plasma volume and on some serum proteins in patients with sickle cell anemia and in sexually impotent men.

Authors:  B Lundh; F H Gardner
Journal:  Scand J Clin Lab Invest       Date:  1971-09       Impact factor: 1.713

Review 9.  Hemolysis and free hemoglobin revisited: exploring hemoglobin and hemin scavengers as a novel class of therapeutic proteins.

Authors:  Dominik J Schaer; Paul W Buehler; Abdu I Alayash; John D Belcher; Gregory M Vercellotti
Journal:  Blood       Date:  2012-12-20       Impact factor: 22.113

10.  Haptoglobin and hemopexin inhibit vaso-occlusion and inflammation in murine sickle cell disease: Role of heme oxygenase-1 induction.

Authors:  John D Belcher; Chunsheng Chen; Julia Nguyen; Fuad Abdulla; Ping Zhang; Hao Nguyen; Phong Nguyen; Trevor Killeen; Sylvia M Miescher; Nathan Brinkman; Karl A Nath; Clifford J Steer; Gregory M Vercellotti
Journal:  PLoS One       Date:  2018-04-25       Impact factor: 3.240
View more
  14 in total

Review 1.  cGMP modulation therapeutics for sickle cell disease.

Authors:  Nicola Conran; Lidiane Torres
Journal:  Exp Biol Med (Maywood)       Date:  2019-01-28

2.  Lessons for the pathogenesis of vasospasm from a patient with sickle cell disease, moyamoya disease, subarachnoid hemorrhage, and 1 month of persistent vasospasm: illustrative case.

Authors:  William D Haselden; Patrick J Drew; Ephraim W Church
Journal:  J Neurosurg Case Lessons       Date:  2022-07-04

3.  Evaluation of the relationship between intravascular hemolysis and clinical manifestations in sickle cell disease: decreased hemopexin during vaso-occlusive crises and increased inflammation in acute chest syndrome.

Authors:  Nazim Yildirim; Selma Unal; Ahmet Yalcinkaya; Feryal Karahan; Yesim Oztas
Journal:  Ann Hematol       Date:  2021-09-25       Impact factor: 3.673

4.  Vasculo-toxic and pro-inflammatory action of unbound haemoglobin, haem and iron in transfusion-dependent patients with haemolytic anaemias.

Authors:  Francesca Vinchi; Richard Sparla; Sara T Passos; Richa Sharma; S Zebulon Vance; Hala S Zreid; Hesham Juaidi; Deepa Manwani; Karina Yazdanbakhsh; Vijay Nandi; André M N Silva; Anand R Agarvas; Eitan Fibach; John D Belcher; Gregory M Vercellotti; Husam Ghoti; Martina U Muckenthaler
Journal:  Br J Haematol       Date:  2021-03-15       Impact factor: 6.998

5.  Excess heme upregulates heme oxygenase 1 and promotes cardiac ferroptosis in mice with sickle cell disease.

Authors:  Archita Venugopal Menon; Jing Liu; Hanting Phoebe Tsai; Lingxue Zeng; Seungjeong Yang; Aarti Asnani; Jonghan Kim
Journal:  Blood       Date:  2022-02-10       Impact factor: 25.476

Review 6.  Sickle Cell Disease: A Paradigm for Venous Thrombosis Pathophysiology.

Authors:  Maria A Lizarralde-Iragorri; Arun S Shet
Journal:  Int J Mol Sci       Date:  2020-07-25       Impact factor: 5.923

Review 7.  The Worst Things in Life are Free: The Role of Free Heme in Sickle Cell Disease.

Authors:  Oluwabukola T Gbotosho; Maria G Kapetanaki; Gregory J Kato
Journal:  Front Immunol       Date:  2021-01-27       Impact factor: 7.561

8.  Heme as Possible Contributing Factor in the Evolvement of Shiga-Toxin Escherichia coli Induced Hemolytic-Uremic Syndrome.

Authors:  Kioa L Wijnsma; Susan T Veissi; Sem de Wijs; Thea van der Velden; Elena B Volokhina; Frank A D T G Wagener; Nicole C A J van de Kar; L P van den Heuvel
Journal:  Front Immunol       Date:  2020-12-22       Impact factor: 7.561

Review 9.  Critical Role of Hemopexin Mediated Cytoprotection in the Pathophysiology of Sickle Cell Disease.

Authors:  Rani Ashouri; Madison Fangman; Alicia Burris; Miriam O Ezenwa; Diana J Wilkie; Sylvain Doré
Journal:  Int J Mol Sci       Date:  2021-06-15       Impact factor: 5.923

10.  Heme Induces IL-6 and Cardiac Hypertrophy Genes Transcripts in Sickle Cell Mice.

Authors:  Oluwabukola T Gbotosho; Maria G Kapetanaki; Samit Ghosh; Flordeliza S Villanueva; Solomon F Ofori-Acquah; Gregory J Kato
Journal:  Front Immunol       Date:  2020-08-21       Impact factor: 7.561
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.